domingo, 16 de febrero de 2020

From bench to bedside, biologics require excellence at every stage - STAT

From bench to bedside, biologics require excellence at every stage - STAT

First Opinion

From bench to bedside, biologics require excellence at every stage

By LEAH CHRISTL


ADOBE
Companies that manufacturer biologics, including biosimilars, around the globe must be deeply committed to making quality therapies.

No hay comentarios: